Pramodini Medicare Limited IPO Details

Factual IPO information from public filings. Not investment advice.

Issue Details

Price Band
₹110 – ₹118
Lot Size
1,200 shares
Min. Investment
₹1,41,600
Total Issue Size
₹69.04 Cr
58,51,200 shares
Fresh Issue
₹63.14 Cr
53,50,800 shares
Offer for Sale
₹5.9 Cr
5,00,400 shares
Face Value
₹10 per share
Issue Type
Book-built IPO
Listing At
NSE SME
Shares Pre-Issue
1,66,94,795
Shares Post-Issue
2,20,45,595

Lot Size & Investment

1 lot = 1,200 shares

Retail (min)

2 lots · 2,400 shares

Retail (max)

2 lots · 2,400 shares

S-HNI (min)

3 lots · 3,600 shares

ApplicationLotsSharesAmount
Retail22,400₹2,83,200
Small HNI (S-HNI)33,600₹4,24,800
Big HNI (B-HNI)89,600₹11,32,800

Financial Performance

Restated figures in ₹ crore, unless stated otherwise

Financial performance by period
PeriodMar-26Mar-25Mar-24
Assets93.6256.4548.78
Total Income63.3838.5535.79
Profit After Tax17.3811.147.14
EBITDA30.920.9715.53
Net Worth53.1535.7724.75
Reserves & Surplus36.4634.4923.46
Total Borrowing17.8510.8111.96

Key Performance Indicators

Key performance indicators
PeriodMar-26
ROE (%)39.08
ROCE (%)34.66
EPS (₹)10.41
P/E (pre-issue)11.34
P/E (post-issue)14.97

About Pramodini Medicare Limited

Incorporated in 2000, Pramodini Medicare Limited is a diagnostic service provider in India offering technology-enabled diagnostic services across radiology, clinical laboratory, and nuclear medicine segments. The company provides services to public hospitals, private hospitals, public sector undertakings (PSUs), medical colleges, and private diagnostic centres across tier I, II, and III cities. Its service portfolio includes radiology services such as MRI, CT scans, X-ray, ultrasound with colour doppler, mammography, Dexa scan, and interventional radiology; clinical laboratory services including haematology, microbiology, immunology, pathology, and biochemistry; and nuclear medicine services such as PET-CT, SPECT, and nuclear therapy. The company also operates a 24×7 teleradiology unit from Vijayawada and a processing laboratory at the same location. Service Model Public-Private Partnership (PPP): Operates diagnostic centres within government hospitals and medical colleges through long-term MOUs. Private-Private Partnership (Pvt-Pvt): Establishes and manages diagnostic centres inside private hospitals under partnership agreements. Strategic Partnerships with PSUs: Collaborates with Government of India PSUs to operate diagnostic and imaging centres across multiple states. Standalone Diagnostic Centres: Operates its own diagnostic centres and laboratories, serving both individual patients and hospitals. Location-Specific Agreements: Each diagnostic centre operates under separate MOUs or contracts with terms customized for the respective location. The business operates through four models: public-private partnership (PPP) with government hospitals and teaching institutions, private-private partnerships with hospitals, strategic partnerships with PSUs, and standalone private diagnostic centres. As of August 04, 2026, the company operated 16 diagnostic centres across seven states. As of March 31, 2026, the company had 161permanent employees. Competitive Strengths: Establishing a strategic presence across various states of India. Strengthening its network through diversified business models. Strong technical capabilities supported by robust IT infrastructure. Experienced management team with significant industry expertise. Consistent track record of revenue growth and financial performance. Diverse customer base, including hospitals, institutions, and individual patients.

Company Information

Book running lead managers
  • Smart Horizon Capital Advisors Pvt.Ltd.
Registered office
D. No: - 29-4-54K, CSI Complex,, Prakasam Road,, Suryaraopet, Vijayawada, Andhra Pradesh, 520002
Market maker
Shreni Shares Ltd., Rainbow Securities Pvt.Ltd.

← Back to Pramodini Medicare Limited IPO